Key result
Elderly T2D patients with CVD exhibit greater glycemic variability and more arrhythmias than middle-aged patients.
Why the study?
Little is known about whether the influence of glycemic variability on arrhythmia is related to age in type 2 diabetes mellitus.
Does glycemic variability increase the risk of arrhythmias more in elderly compared to middle-aged patients with type 2 diabetes mellitus?
Cross-Sectional (n=107)
No
Does glycemic variability increase the risk of arrhythmias more in elderly compared to middle-aged patients with type 2 diabetes mellitus?
Absolute Event Rate: 5.77% vs 4.63%
p-value: p=0.026
Elderly patients with type 2 diabetes exhibit greater glycemic variability, which is associated with an increased risk of arrhythmias, highlighting the importance of stable blood glucose control in this population.
Greater GV linked to more arrhythmias in elderly vs middle-aged T2DM; leaves open whether GV control reduces arrhythmia risk.
BACKGROUND: Little is known about whether the influence of glycemic variability on arrhythmia is related to age in type 2 diabetes mellitus (T2DM). Therefore, we aimed to compare the association between glycemic variability and arrhythmia in middle-aged and elderly T2DM patients. METHODS: A total of 107 patients were divided into two groups: elderly diabetes mellitus group (EDM, n = 73) and middle-aged diabetes mellitus group (MDM, n = 34). The main clinical data, continuous glucose monitoring (CGM) and dynamic ECG reports were collected. The parameters including standard deviation of blood glucose (SDBG), largest amplitude of glycemic excursions (LAGE), mean amplitude of glycemic excursions (MAGE), absolute means of daily differences (MODD), time in range (TIR), time below range (TBR), time above range (TAR), coefficient of variation (CV) were tested for glycemic variability evaluation. RESULTS: In terms of blood glucose fluctuations, MAGE (5.77 ± 2.16 mmol/L vs 4.63 ± 1.89 mmol/L, P = 0.026), SDBG (2.39 ± 1.00 mmol/L vs 2.00 ± 0.82 mmol/L, P = 0.048), LAGE (9.53 ± 3.37 mmol/L vs 7.84 ± 2.64 mmol/L, P = 0.011) was significantly higher in EDM group than those of MDM group. The incidences of atrial premature beat, couplets of atrial premature beat, atrial tachycardia and ventricular premature beat were significantly higher in EDM group compared with the MDM group (all P < 0.05). Among patients with hypoglycemia events, the incidences of atrial premature beat, couplets of atrial premature beat, atrial tachycardia and ventricular premature beat (all P < 0.05) were significantly higher in the EDM group than those in the MDM group. In EDM group, TIR was negatively correlated with atrial tachycardia in the MAGE1 layer and with atrial tachycardia and ventricular premature beat in the MAGE2 layer, TBR was significantly positively correlated with atrial tachycardia in the MAGE2 layer (all P < 0.05). In MDM group, TAR was positively correlated with ventricular premature beat and atrial tachycardia in the MAGE2 layer (all P < 0.05). CONCLUSIONS: The study demonstrated the elderly patients had greater glycemic variability and were more prone to arrhythmias. Therefore, active control of blood glucose fluctuation in elderly patients will help to reduce the risk of severe arrhythmia.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted a cross-sectional in Type 2 diabetes mellitus with chronic cardiovascular disease (n=107). Elderly age (≥65 years) vs. Middle-aged (45-64 years) was evaluated on Mean amplitude of glycemic excursions (MAGE) in mmol/L (p=0.026). Elderly patients with type 2 diabetes and cardiovascular disease exhibited significantly greater glycemic variability (MAGE 5.77 vs 4.63 mmol/L, P=0.026) and a higher incidence of arrhythmias compared to middle-aged patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: